The Teal Journal is back, with a fresh look and a new spotlight on survivorship! Our online publication still includes the reports you love on ground-breaking research and the happenings on Capitol Hill.
In Issue VI we discuss the pending “fiscal cliff” and what it could mean for cancer research if Congress doesn’t act. We look at research exploring two ways of using folate receptors in treatment of ovarian cancer; as this issue went to press we learned that one company has applied for approval of its folate receptor drug in the European Union. Alice Spinelli, a nurse practitioner specializing in gynecologic cancers, answers questions about how ovarian cancer research advanced in 2012. In a new feature, long-term survivor Joan Sommer shares her story and some tips for coping with ovarian cancer recurrence.
We hope you enjoy Issue VI of The Teal Journal! We’d love to know what you think of this publication–you can email us at email@example.com, call the Alliance at (202) 331-1332 or leave a comment on our Facebook page.